Video

Overview of Presbyopia

Author(s):

S. Barry Eiden, OD, FAAO,Francis S. Mah, MD

Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
(Image credit: AdobeStock/©rh2010)
April 10th 2025

Presbyopia treatment success begins with patient-centered care

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
March 29th 2024

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: AdobeStock/auremar)
April 7th 2025

Orasis Pharmaceuticals’ prescription pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for presbyopia available in the US

Podcast: Talking about the anterior segment pipeline for 2023
March 29th 2023

Podcast: Talking about the anterior segment pipeline for 2023

(Image credit: AdobeStock/Vitalii Vodolazskyi)
February 6th 2025

Exploring presbyopia progression in patients with glaucoma treated with PF receptor agonists

Tenpoint Therapeutics announces positive topline results from Phase 3 pivotal trial BRIO-II assessing BRIMOCHOL PF for the treatment of presbyopia
January 10th 2025

Tenpoint Therapeutics announces positive topline results from Phase 3 pivotal trial BRIO-II assessing BRIMOCHOL PF for the treatment of presbyopia

© 2025 MJH Life Sciences

All rights reserved.